Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 201–300 of 999
Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1
Toffoli, S., Roegiers, A., Féron, O., Steenbrugge, M. V., Ninane, N., Raes, M. J., & Michiels, C. (2009) · Angiogenesis · doi:10.1007/s10456-009-9131-y · Cited by 108
Ježek, P., Plecitá‐Hlavatá, L., Smolková, K., & Rossignol, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.008 · Cited by 109
Vascular disrupting agents in cancer therapy
Smolarczyk, R., Czapla, J., Jarosz–Biej, M., Czerwinski, K., & Cichoń, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173692 · Cited by 92
Zhang, P., Huang, H., Chen, Y., Wang, J., Ji, L., & Chao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.126 · Cited by 94
Aburjania, Z., Jang, S., Whitt, J. D., Jaskula-Stzul, R., Chen, H., & Rose, J. B. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0677 · Cited by 98
Dai, Y., Lin, X., Xu, W., Lin, X., Huang, Q., Shi, L., Pan, Y., Zhang, Y., Zhu, Y., Li, C., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1395-6 · Cited by 88
Tovmasyan, A. G., Sheng, H., Weitner, T., Arulpragasam, A. R., Lu, M., Warner, D. S., Vujašković, Ž., Spasojević, I., & Batinic̈‐Haberle, I. (2012) · Medical Principles and Practice · doi:10.1159/000341715 · Cited by 98
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 91
Shen, L., Huang, X., Xie, X., Su, J., Yuan, J. J., & Chen, X. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414532654 · Cited by 90
Targeting hypoxic response for cancer therapy
Paolicchi, E., Gemignani, F., Krstic-Demonacos, M., Dedhar, S., Mutti, L., & Landi, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7229 · Cited by 88
Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3
Prickaerts, P., Adriaens, M. E., Beucken, T. V. D., Koch, E., Dubois, L., Dahlmans, V. E. H., Gits, C., Evelo, C. T. A., Chan-Seng-Yue, M., Wouters, B. G., et al. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0086-0 · Cited by 87
Rational construction of a reversible arylazo-based NIR probe for cycling hypoxia imaging in vivo
Zhang, Y., Zhao, W., Chen, Y., Yuan, H., Fang, H., Yao, S., Zhang, C., Xu, H., Li, N., Liu, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22855-0 · Cited by 91
Reactive oxygen species in cancer progression and its role in therapeutics
Singh, R. K., & Manna, P. P. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00073 · Cited by 104
Myeloid-Derived Suppressor Cells and Radiotherapy
Jiménez‐Cortegana, C., Galassi, C., Klapp, V., Gabrilovich, D. I., & Galluzzi, L. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-1105 · Cited by 93
Yaromina, A., Thames, H. D., Zhou, X., Hering, S., Eicheler, W., Dörfler, A., Leichtner, T., Zips, D., & Baumann, M. A. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.020 · Cited by 96
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Pavlopoulou, A., Oktay, Y., Vougas, K. N., Louka, M. A., Vorgias, C. E., & Georgakilas, A. G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.018 · Cited by 94
Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma
Coffman, L. G., Pearson, A. T., Frisbie, L. G., Freeman, Z., Christie, E., Bowtell, D. D., & Buckanovich, R. J. (2019) · Stem Cells · doi:10.1002/stem.2932 · Cited by 86
Glioma Stem Cell Maintenance: The Role of the Microenvironment
Heddleston, J. M., Hitomi, M., Venere, M., Flavahan, W. A., Yang, K., Kim, Y., Minhas, S., Rich, J. N., & Hjelmeland, A. B. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797249260 · Cited by 100
Hypoxia-tropic nanozymes as oxygen generators for tumor-favoring theranostics
Gao, F., Wu, J., Gao, H., Hu, X., Liu, L., Midgley, A. C., Liu, Q., Sun, Z., Liu, Y., Ding, D., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119635 · Cited by 85
Targeting solid tumors with non‐pathogenic obligate anaerobic bacteria
Taniguchi, S., Fujimori, M., Sasaki, T., Tsutsui, H., Shimatani, Y., Seki, K., & Amano, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01628.x · Cited by 85
Hypoxia and Predicting Radiation Response
Hill, R. P., Bristow, R. G., Fyles, A., Koritzinsky, M., Milosevic, M., & Wouters, B. G. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.004 · Cited by 101
Azad, P., Zhou, D., Heinrichsen, E. T., & Haddad, G. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005371 · Cited by 88
Hypoxia-Adaptation Involves Mitochondrial Metabolic Depression and Decreased ROS Leakage
Ali, S. S., Hsiao, M., Zhao, H. W., Dugan, L. L., Haddad, G. G., & Zhou, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036801 · Cited by 85
Research progress on tumor hypoxia-associative nanomedicine
Xu, X., Chen, S., Yi, N.-B., Li, X., Chen, S., Lei, Z., Cheng, D., & Sun, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.003 · Cited by 88
Singleton, R. S., Guise, C. P., Ferry, D. M., Pullen, S. M., Dorie, M. J., Brown, J. M., Patterson, A. V., & Wilson, W. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4023 · Cited by 87
The future of biology in driving the field of hyperthermia
Dewhirst, M. W., Lee, C.-T., & Ashcraft, K. A. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1091093 · Cited by 89
Self-citationHypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia
Huang, X., Zhuang, J., Chung, S. W., Huang, B., Halpert, G., Negrón, K., Sun, X., Yang, J., Oh, Y., Hwang, P. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05399 · Cited by 84
Zhang, X., Ashcraft, K. A., Warner, A. B., Nair, S. K., & Dewhirst, M. W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2468 · Cited by 98
Self-citationPeña-Rico, M. Á., Calvo-Vidal, M. N., Villalonga-Planells, R., Martínez‐Soler, F., Gimenez‐Bonafé, P., Navarro‐Sabaté, À., Tortosa, A., Bartrons, R., & Manzano, À. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.002 · Cited by 80
The twisted survivin connection to angiogenesis
Sanhueza, C. T., Wehinger, S., Bennett, J., Valenzuela, M., Owen, G. I., & Quest, A. F. G. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0467-1 · Cited by 93
Bielecka, Z. F., Czarnecka, A. M., Solarek, W., Kornakiewicz, A., & Szczylik, C. A. (2014) · Current Signal Transduction Therapy · doi:10.2174/1574362409666140206223014 · Cited by 89
Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells
Bhaskara, V. K., Mohanam, I., Rao, J. S., & Mohanam, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030905 · Cited by 79
Román, Á., Carvajal-González, J. M., Rico-Leo, E. M., & Fernández‐Salguero, P. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013292 · Cited by 92
Optical imaging of tumor hypoxia dynamics
Palmer, G. M., Fontanella, A. N., Zhang, G., Hanna, G., Fraser, C. L., & Dewhirst, M. W. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3523363 · Cited by 85
Self-citationSelf-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
Yokota, N., Koizume, S., Miyagi, E., Hirahara, F., Nakamura, Y., Kikuchi, K., Ruf, W., Sakuma, Y., Tsuchiya, E., & Miyagi, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605406 · Cited by 77
Stiehl, D. P., Bordoli, M. R., Abreu‐Rodríguez, I., Wollenick, K., Schraml, P., Gradin, K., Poellinger, L., Kristiansen, G., & Wenger, R. H. (2011) · Oncogene · doi:10.1038/onc.2011.417 · Cited by 86
The growing complexity of HIF-1α’s role in tumorigenesis: DNA repair and beyond
Rohwer, N., Zasada, C., Kempa, S., & Cramer, T. (2012) · Oncogene · doi:10.1038/onc.2012.510 · Cited by 88
Radiotherapy: An immune response modifier for immuno-oncology
Martino, M. D., Daviaud, C., & Vanpouille‐Box, C. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101474 · Cited by 88
MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors
Kitamoto, S., Yokoyama, S., Higashi, M., Yamada, N., Takao, S., & Yonezawa, S. (2012) · Oncogene · doi:10.1038/onc.2012.478 · Cited by 85
Une, N., Takano-Kasuya, M., Kitamura, N., Ohta, M., Inose, T., Kato, C., Nishimura, R., Tada, H., Miyagi, S., Ishida, T., et al. (2021) · Medical Oncology · doi:10.1007/s12032-021-01503-z · Cited by 82
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
Hatfield, S. M., & Sitkovsky, M. V. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137554 · Cited by 73
Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics
Nigam, M., Punia, B., Dimri, D. B., Mishra, A. P., Radu, A.-F., & Bungau, G. S. (2025) · Cells · doi:10.3390/cells14151207 · Cited by 94
Fluorescent microparticles for sensing cell microenvironment oxygen levels within 3D scaffolds
Acosta, M. A., Ymele-Leki, P., Kostov, Y. V., & Leach, J. B. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.021 · Cited by 73
Combining angiogenesis inhibition and radiotherapy: A double-edged sword
Kleibeuker, E. A., Griffioen, A. W., Verheul, H. M. W., Slotman, B. J., & Thijssen, V. L. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.04.002 · Cited by 81
Simultaneous intracellular redox potential and pH measurements in live cells using SERS nanosensors
Jamieson, L. E., Jaworska, A., Jiang, J., Barańśka, M., Harrison, D. J., & Campbell, C. J. (2015) · The Analyst · doi:10.1039/c4an02365j · Cited by 87
Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics
Fu, Q., Duan, R., Sun, Y., & Li, Q. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102352 · Cited by 84
Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy
Ding, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., & He, B. (2023) · Biomaterials Science · doi:10.1039/d2bm01833k · Cited by 73
Meng, L., Cheng, Y., Gan, S., Zhang, Z., Tong, X., Xu, L., Jiang, X., Zhu, Y., Wu, J., Yuan, A., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00808 · Cited by 69
Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis
Galvis, M. M., & Teng, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155487 · Cited by 76
Reactive oxygen nano-generators for cancer therapy
Kalyane, D., Choudhary, D., Polaka, S., Goykar, H., Karanwad, T. R., Rajpoot, K., & Tekade, R. K. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2022.100974 · Cited by 75
Moding, E. J., Clark, D. P., Qi, Y. P., Li, Y., Ma, Y., Ghaghada, K. B., Johnson, G. A., Kirsch, D. G., & Badea, C. T. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.09.027 · Cited by 69
Directing systemic oncolytic viral delivery to tumors via carrier cells☆
Nakashima, H., Kaur, B., & Chiocca, E. A. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.004 · Cited by 70
Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
Yeom, C., Goto, Y., Zhu, Y., Hiraoka, M., & Harada, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113949 · Cited by 69
Gu, Y., Patterson, A. V., Atwell, G. J., Chernikova, S. B., Brown, J. M., Thompson, L. H., & Wilson, W. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1209 · Cited by 69
Chen, W.-L., Wang, C.-C., Lin, Y., Wu, C., & Hsieh, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0758-8 · Cited by 72
Recent Progress in the Design of Hypoxia‐Specific Nano Drug Delivery Systems for Cancer Therapy
Sahu, A., Choi, W. I., & Tae, G. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800026 · Cited by 68
Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival
Allegra, A., Caserta, S., Genovese, S., Pioggia, G., & Gangemi, S. (2023) · Antioxidants · doi:10.3390/antiox12061255 · Cited by 76
Jia, J.-B., Wang, W., Sun, H., Zhu, X., Liu, L., Zhuang, P., Zhang, J., Zhang, W., Xu, H., Kong, L., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0170 · Cited by 71
Exercise and the Tumor Microenvironment: Potential Therapeutic Implications
Wiggins, J. M., Opoku‐Acheampong, A. B., Baumfalk, D. R., Siemann, D. W., & Behnke, B. J. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000137 · Cited by 74
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Liu, X., Su, Q., Zhang, X., Yang, W., Ning, J., Jia, K., Xin, J., Li, H., Yu, L., Liao, Y., et al. (2022) · Biosensors · doi:10.3390/bios12111045 · Cited by 76
Longitudinal optical imaging of tumor metabolism and hemodynamics
Skala, M. C., Fontanella, A. N., Lan, L., Izatt, J. A., & Dewhirst, M. W. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3285584 · Cited by 72
Self-citationZhang, Y., Dang, M., Tian, Y., Zhu, Y., Liu, W., Tian, W., Su, Y., Ni, Q., Xu, C., Lu, N., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10840 · Cited by 69
Zhang, H., Zhang, X., Ren, Y., Cao, F., Hou, L., & Zhang, Z. (2019) · Theranostics · doi:10.7150/thno.33141 · Cited by 69
Yaromina, A., Kroeber, T., Meinzer, A., Boeke, S., Thames, H. D., Baumann, M. A., & Zips, D. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.015 · Cited by 75
Hsieh, C., Wu, C., Lee, H., Liang, J., Yu, C.-Y., & Lin, Y. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.009 · Cited by 71
Role of thyroid hormones in the neoplastic process: an overview
Goemann, I. M., Romitti, M., Meyer, E. L. D. S., Wajner, S. M., & Maia, A. L. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0192 · Cited by 71
Augustine, R., Dalvi, Y. B., Dan, P., George, N., Helle, D. U., Varghese, R., Thomas, S., Menu, P., & Sandhyarani, N. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01102 · Cited by 67
Role of Reactive Oxygen Species in Cancer Progression
Kashyap, D., Tuli, H. S., Sak, K., Garg, V. K., Goel, N., Punia, S., & Chaudhary, A. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00171-y · Cited by 74
Barabutis, N., & Schally, A. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811209106 · Cited by 66
HIF targets in bone remodeling and metastatic disease
Johnson, R. W., Schipani, E., & Giaccia, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.02.002 · Cited by 70
Goos, J. A. C. M., de Cuba, E. M. V., Coupé, V. M. H., Diosdado, B., Diemen, P. M. D., Karga, C., Beliën, J. A. M., van Oordt, C. W. M. D. H., Geldof, A. A., Meijer, G. A., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001109 · Cited by 65
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Gérard, M., Corroyer‐Dulmont, A., Lesueur, P., Collet, S., Chérel, M., Bourgeois, M., Stefan, D., Limkin, E. J., Perrio, C., Guillamo, J., et al. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00117 · Cited by 69
Impact of Stromal Sensitivity on Radiation Response of Tumors Implanted in SCID Hosts Revisited
García-Barros, M., Thin, T. H., Maj, J., Cordon‐Cardo, C., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1871 · Cited by 67
Pt nanozyme for O 2 self-sufficient, tumor-specific oxidative damage and drug resistance reversal
Ma, Z., Wu, L. B., Han, K., & Han, H. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00088g · Cited by 63
Alonzi, R., Padhani, A. R., Taylor, N. J., Collins, D. J., d’Arcy, J. A., Stirling, J., Saunders, M. I., & Hoskin, P. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.02.060 · Cited by 63
Leung, E., Cairns, R. A., Chaudary, N., Vellanki, R. N., Kalliomäki, T., Moriyama, E. H., Mujčić, H., Wilson, B. C., Wouters, B. G., Hill, R. P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3402-6 · Cited by 70
Yonashiro, R., Eguchi, K., Wake, M., Takeda, N., & Nakayama, K. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1751 · Cited by 64
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Sun, L., Cao, Y., Lu, Z., Ding, P., Wang, Z., Ma, F., Wang, Z., & Pei, R. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101434 · Cited by 65
Self-citationGiang, A., Raymond, T., Brookes, P. S., Bentley, K. L. D. M., Schwarz, E. M., O’Keefe, R. J., & Eliseev, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507129 · Cited by 62
Chemical analysis of multicellular tumour spheroids
Jamieson, L. E., Harrison, D. J., & Campbell, C. J. (2015) · The Analyst · doi:10.1039/c5an00524h · Cited by 68
Shi, Z., Hu, C., Zheng, X., Sun, C., & Li, Q. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00519-1 · Cited by 75
“Cancer cells can adapt to hypoxia by undergoing metabolic reprogramming [9], resulting in a series of adaptive responses that culminate in enhanced resistance to radiation [10].”
BackgroundCellular and Molecular Mechanisms Underlying Oxygen-Dependent Radiosensitivity
Liu, C., Lin, Q., & Yun, Z. (2015) · Radiation Research · doi:10.1667/rr13959.1 · Cited by 68
Lai, M., Chang, C.-M., & Sun, H. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153627 · Cited by 79
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
Gargini, R., Segura‐Collar, B., & Gómez, P. S. (2020) · Cancers · doi:10.3390/cancers12061622 · Cited by 64
Carbon Ions for Hypoxic Tumors: Are We Making the Most of Them?
Sokol, O., & Durante, M. (2023) · Cancers · doi:10.3390/cancers15184494 · Cited by 58
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
Emblem, K. E., Farrar, C. T., Gerstner, E. R., Batchelor, T. T., Borra, R. J. H., Rosen, B. R., Sorensen, A. G., & Jain, R. K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.126 · Cited by 59
Chen, L., Liu, H.-P., Li, H.-P., Hsueh, C., Yu, J., Liang, C.-L., & Chang, Y.-S. (2009) · Oncogene · doi:10.1038/onc.2009.55 · Cited by 57
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia–cell cycle dual reporter
Le, A., Stine, Z. E., Nguyen, C., Afzal, J., Sun, P., Hamaker, M., Siegel, N. M., Gouw, A. M., Kang, B.-H., Yu, S.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402012111 · Cited by 58
Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging
Dewhirst, M. W., & Birer, S. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2818 · Cited by 68
Self-citationCrosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
Noman, M. Z., Messai, Y., Muret, J. C., Hasmim, M., & Chouaïb, S. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0157-3 · Cited by 61
HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells
Zhang, H., Lu, C., Fang, M., Yan, W., Chen, M., Ji, Y., He, S., Liu, T., Chen, T., & Xiao, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.026 · Cited by 58
Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry
Quirós-González, I., Tomaszewski, M. R., Aitken, S. J., Ansel-Bollepalli, L., McDuffus, L., Gill, M., Hacker, L., Brunker, J., & Bohndiek, S. E. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0033-x · Cited by 58
Advanced nanomaterials targeting hypoxia to enhance radiotherapy
Li, J., Shang, W., Li, Y., Fu, S., Tian, J., & Lu, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173914 · Cited by 59
Fabrication of H 2 O 2 -driven nanoreactors for innovative cancer treatments
Dong, Z., Yang, Z., Hao, Y., & Feng, L. (2019) · Nanoscale · doi:10.1039/c9nr04418c · Cited by 57
Guo, L., Li, L., Wang, W., Pan, Z., Zhou, Q., & Wu, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.004 · Cited by 56
Hypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 61
Sequential Intercellular Delivery Nanosystem for Enhancing ROS-Induced Antitumor Therapy
Wang, B., Zhang, H., An, J., Zhang, Y., Sun, L., Jin, Y., Shi, J., Li, M., Zhang, H., & Zhang, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00336 · Cited by 54
Recent advances in functional nanomaterials for X-ray triggered cancer therapy
Liu, T., Yang, K., & Liu, Z. (2020) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2020.09.009 · Cited by 57
Subtil, F. S. B., Wilhelm, J., Bill, V., Westholt, N., Rudolph, S., Fischer, J., Scheel, S., Seay, U., Fournier, C., Taucher-Scholz, G., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-242230 · Cited by 61
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.